Auch wir verwenden Cookies. Mehr Informationen in der Datenschutzerklärung

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Viking Therepautics a Buy Now?

TheMotleyFool

0 0

Is Viking Therepautics a Buy Now?Photo, wide shot, wide-angle lens, soft focus, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D

Shares of Viking Therapeutics (NASDAQ: VKTX) fell on Monday, Nov. 4, despite some encouraging new data. Over the weekend, the company showed the medical community and investors results that suggest its experimental anti-obesity tablet, tentatively named VK2735, could go on to generate blockbuster sales.

Viking's previous positive results for the experimental treatments in its pipeline haven't gone unnoticed by the overall stock market. The stock has risen about 256% in 2024.

Let's look at the latest trial results from Viking Therapeutics to see if it's a smart buy now despite already soaring this year.

Source Fool.com